A Clinical Trial on the Efficacy and Safety of TQB6411 for Injection

Clinical trial NCT07367529 · RECRUITING

Trial details

NCT number: NCT07367529
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Lung Cancer

Start date: 2026-02-26
Primary completion: 2028-12-01
Enrollment: 465

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.